Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Revenue (Quarterly): 12.11M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 12.11M |
March 31, 2024 | 14.68M |
December 31, 2023 | 12.11M |
September 30, 2023 | 3.786M |
June 30, 2023 | 2.938M |
March 31, 2023 | 3.935M |
December 31, 2022 | 4.129M |
September 30, 2022 | 4.135M |
Date | Value |
---|---|
June 30, 2022 | 3.776M |
March 31, 2022 | 5.935M |
December 31, 2021 | 4.856M |
September 30, 2021 | 10.62M |
June 30, 2021 | 3.197M |
March 31, 2021 | 2.66M |
December 31, 2020 | 3.243M |
September 30, 2020 | 3.355M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.66M
Minimum
Mar 2021
14.68M
Maximum
Mar 2024
5.967M
Average
4.032M
Median
Revenue (Quarterly) Benchmarks
Eli Lilly and Co | 11.44B |
Dentsply Sirona Inc | 951.00M |
Ligand Pharmaceuticals Inc | 51.81M |
NovaBay Pharmaceuticals Inc | 2.441M |
Palatin Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -6.488M |
Total Expenses (Quarterly) | 22.29M |
EPS Diluted (Quarterly) | -0.30 |
Enterprise Value | 101.21M |
Gross Profit Margin (Quarterly) | 82.47% |
Profit Margin (Quarterly) | -53.57% |
Earnings Yield | -211.5% |
Normalized Earnings Yield | -51.19 |